DMS Group obtains FDA approval for the !M1

DMS Group has achieved a strategic milestone in the United States with FDA approval of its !M1 mobile radiology system. This success strengthens its partnership with JPI Healthcare Solutions for the commercialization of !M1 in the US market. The official launch of the solution, under the name TrueMobile Apex, will take place at RSNA 2025 in Chicago.

The US market, considered dynamic for medical imaging solutions, is a priority for DMS Group. The company has already recorded significant revenue growth of 93% in North America for the first nine months of 2025, reaching €5.1 million. The system also integrates Trixell's advanced Pixum EZ-C X detector.